252 related articles for article (PubMed ID: 11290585)
21. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.
Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE
Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
[TBL] [Abstract][Full Text] [Related]
23. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
24. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).
Gu TL; Goetz TL; Graves BJ; Speck NA
Mol Cell Biol; 2000 Jan; 20(1):91-103. PubMed ID: 10594012
[TBL] [Abstract][Full Text] [Related]
25. Core binding factor and its role in normal hematopoietic development.
Speck NA
Curr Opin Hematol; 2001 Jul; 8(4):192-6. PubMed ID: 11561154
[TBL] [Abstract][Full Text] [Related]
26. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein.
Hajra A; Liu PP; Speck NA; Collins FS
Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
[TBL] [Abstract][Full Text] [Related]
29. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
Pulikkan JA; Hegde M; Ahmad HM; Belaghzal H; Illendula A; Yu J; O'Hagan K; Ou J; Muller-Tidow C; Wolfe SA; Zhu LJ; Dekker J; Bushweller JH; Castilla LH
Cell; 2018 Jun; 174(1):172-186.e21. PubMed ID: 29958106
[TBL] [Abstract][Full Text] [Related]
30. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
Kuo YH; Zaidi SK; Gornostaeva S; Komori T; Stein GS; Castilla LH
Blood; 2009 Apr; 113(14):3323-32. PubMed ID: 19179305
[TBL] [Abstract][Full Text] [Related]
31. Acceleration of G(1) cooperates with core binding factor beta-smooth muscle myosin heavy chain to induce acute leukemia in mice.
Yang Y; Wang W; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
Cancer Res; 2002 Apr; 62(8):2232-5. PubMed ID: 11956074
[TBL] [Abstract][Full Text] [Related]
32. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.
Castilla LH; Wijmenga C; Wang Q; Stacy T; Speck NA; Eckhaus M; Marín-Padilla M; Collins FS; Wynshaw-Boris A; Liu PP
Cell; 1996 Nov; 87(4):687-96. PubMed ID: 8929537
[TBL] [Abstract][Full Text] [Related]
33. c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoprotein.
Bernardin F; Yang Y; Civin CI; Friedman AD
Cancer Biol Ther; 2002; 1(5):492-6. PubMed ID: 12496475
[TBL] [Abstract][Full Text] [Related]
34. The core-binding factor beta subunit is required for bone formation and hematopoietic maturation.
Miller J; Horner A; Stacy T; Lowrey C; Lian JB; Stein G; Nuckolls GH; Speck NA
Nat Genet; 2002 Dec; 32(4):645-9. PubMed ID: 12434155
[TBL] [Abstract][Full Text] [Related]
35. Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.
Richter L; Wang Y; Hyde RK
Oncotarget; 2016 Oct; 7(40):66255-66266. PubMed ID: 27542261
[TBL] [Abstract][Full Text] [Related]
36. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - a model for overcoming inhibition of proliferation by CBF oncoproteins.
Lou J; Cao W; Bernardin F; Ayyanathan K; RauscherIII FJ; Friedman AD
Oncogene; 2000 May; 19(22):2695-703. PubMed ID: 10851069
[TBL] [Abstract][Full Text] [Related]
37.
Zhen T; Kwon EM; Zhao L; Hsu J; Hyde RK; Lu Y; Alemu L; Speck NA; Liu PP
Blood; 2017 Nov; 130(22):2431-2442. PubMed ID: 29018080
[TBL] [Abstract][Full Text] [Related]
38. Function of CBFbeta/Bro proteins.
Adya N; Castilla LH; Liu PP
Semin Cell Dev Biol; 2000 Oct; 11(5):361-8. PubMed ID: 11105900
[TBL] [Abstract][Full Text] [Related]
39. AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia.
Downing JR
Leukemia; 2001 Apr; 15(4):664-5. PubMed ID: 11368373
[No Abstract] [Full Text] [Related]
40. Leukemogenesis by CBF oncoproteins.
Friedman AD
Leukemia; 1999 Dec; 13(12):1932-42. PubMed ID: 10602413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
